Molecular Diagnostics
Genetic Signature to Stratify Patients with Early NSCLC
Scientists plan to generate a gene-expression signature that will allow clinicians to stratify patients with early non-small cell lung cancer into those who will relapse after surgery and those who will have disease-free survival with surgery alone. More...22 Sep 2008
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Pipette Calibration System
Artel PCS®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
In Other News
Biochip Array Analyzer Detects Colorectal Cancer-Related Polymorphisms
DNA-Spotted Microarray Developed to Detect Bioterror Pathogens
Molecular Diagnostic Profile Discovered for Prostate Cancer
Kits Measure Relative Abundance of Proteins in Serum
Nanoparticle-Based Laboratory Immunoassay Determines 5-FU Plasma Levels
Assay Measures Susceptibility of HIV to Integrase Inhibitors
Test Determines Origin of Hard-to-Identify Tumors
Biomarkers Identify Patients with Peripheral Ruptured Atherosclerotic Lesions
High-Density Arrays Evaluated for Disease Analysis
DNA Analysis Identifies People with Fabry Disease
Dako to Develop Pharmacodiagnostic Tests for Bristol-Myers Squibb
Warfarin Sensitivity Test Detects Three Genetic Markers
Melanoma Identified by Overexpression of Protein IMP-3
Phadia Introduces Recombinant Control Antibodies into Autoimmune Tests
Companion Diagnostic Cancer Testing Service Expands Internationally
Five Gene Variants Help Predict Sickle Cell Disease Severity
Location of Oncogene-Related Proteins Determines Leukemia Onset
MicroRNAs Differentiate Between Primary and Metastatic Brain Tumors
Assay Determines Breast Cancer's Susceptibility to Herceptin
Cancer Mutation Kit Launched
Aggregated Abeta Is an Indicator of Alzheimer's Disease
Electrostatic-Based DNA Microarray Technique Simplified for Diagnostics
Australian Scientists Develop Genetic Test for Epilepsy
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
